Date: Wednesday 13 January 2021, 4pm-5.15pm
Venue: Online, Zoom link sent to all registered attendees
Register: here
You are warmly invited to the next seminar as part of the Cambridge Academy of Therapeutic Sciences' (CATS) Gateway to Translation (G2T) series of webinars and online events. In this talk, Prof Paul Finn, CEO of Oxford Drug Design (originally InhibOx – spin out from the University of Oxford) and the Founder of Affinity Drug Design Ltd., will discuss the use of Machine Learning and AI in the Drug Discovery process.
All are welcome and the seminar will include a live Q&A session. Please register here and a link to the webinar platform will be sent to all registered attendees prior to the event. Further information about other seminars in the G2T series is available here.
